Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 151-200 of 1147 result(s).
CYDY CytoDyn Inc
05/17/2025 5:28:03 PM
In a patent, around 1800mg is refer (1)
CYDY CytoDyn Inc
05/17/2025 5:26:32 PM
" not just congratulating them on t (1)
CYDY CytoDyn Inc
05/17/2025 4:56:09 PM
Place Blok's ESMO comments in sync: (4)
CYDY CytoDyn Inc
05/16/2025 11:01:40 AM
Post by thriving 4m @my69z The Marc (3)
CYDY CytoDyn Inc
05/16/2025 10:33:30 AM
Now we see why Creativ was so excit (2)
CYDY CytoDyn Inc
05/16/2025 9:02:02 AM
BTG on ST made an absolutely GREAT (4)
CYDY CytoDyn Inc
05/16/2025 6:51:24 AM
Forgot to add --- https://investors
CYDY CytoDyn Inc
05/16/2025 6:49:13 AM
Sounds like it should be -- Thx for (1)
CYDY CytoDyn Inc
05/16/2025 5:52:07 AM
Don't forget our Long Acting patent (3)
CYDY CytoDyn Inc
05/16/2025 2:45:12 AM
I kinda don't think ...late correct (1)
CYDY CytoDyn Inc
05/16/2025 2:09:01 AM
"...but that blows our entire budge (5)
CYDY CytoDyn Inc
05/15/2025 7:45:15 PM
For me, if our confirmation trials (2)
CYDY CytoDyn Inc
05/15/2025 4:00:56 PM
pembrolizumab=Keytruda OS=23 months (3)
CYDY CytoDyn Inc
05/15/2025 3:32:53 PM
Sbowers59 12:52 PM $CYDY Tyler bloc (8)
CYDY CytoDyn Inc
05/15/2025 2:05:20 AM
Can put developmental & all kinds o (2)
CYDY CytoDyn Inc
05/15/2025 1:38:51 AM
“Leronlimab’s ability to induce (2)
CYDY CytoDyn Inc
05/15/2025 1:36:04 AM
From past trial protocol: Outcome M (6)
CYDY CytoDyn Inc
05/14/2025 8:12:29 AM
Hiv resevoir -- that wholy grail -- (2)
CYDY CytoDyn Inc
05/14/2025 7:42:56 AM
Whichever way...the fact cold into (1)
CYDY CytoDyn Inc
05/14/2025 7:33:26 AM
The AAV Vectoring patent -- I think
CYDY CytoDyn Inc
05/14/2025 7:22:53 AM
How (if) do you patent cold into ho
CYDY CytoDyn Inc
05/13/2025 10:18:08 PM
" we believe we could get a synergi (6)
CYDY CytoDyn Inc
05/13/2025 8:51:44 PM
24 - 48 ? --- Follow-up confirmatio (3)
CYDY CytoDyn Inc
05/13/2025 3:35:35 PM
Do you think that 10-20% is this fr (2)
CYDY CytoDyn Inc
05/13/2025 1:18:52 PM
& this why you need to become Senio (2)
CYDY CytoDyn Inc
05/13/2025 12:11:20 PM
Oncology – March 2025 Update The (3)
CYDY CytoDyn Inc
05/13/2025 10:17:12 AM
88% & 100%. Told u our "worst" data (5)
CYDY CytoDyn Inc
05/13/2025 10:05:45 AM
& we have a long acting patent appl (2)
CYDY CytoDyn Inc
05/13/2025 9:30:50 AM
Top Companies with FDA-Approved Che (4)
CYDY CytoDyn Inc
05/13/2025 9:10:53 AM
Long Acting Leronlimab --- They sai (4)
CYDY CytoDyn Inc
05/12/2025 6:49:47 PM
Mr. Vittner on our CRC protocol: Wh (3)
CYDY CytoDyn Inc
05/12/2025 5:51:20 PM
"Can leronlimab, in combination wit (4)
CYDY CytoDyn Inc
05/12/2025 5:25:17 PM
OR...FDA allowed us to skip the ini (5)
CYDY CytoDyn Inc
05/12/2025 5:08:14 PM
From House spending cuts bill: Bars (3)
CYDY CytoDyn Inc
05/12/2025 4:43:30 PM
So we've passed the initial 5 & ont (2)
CYDY CytoDyn Inc
05/12/2025 7:36:41 AM
"....because I naively assumed the (5)
CYDY CytoDyn Inc
05/11/2025 7:46:48 PM
Trump EO on drug pricing out: https (6)
CYDY CytoDyn Inc
05/11/2025 6:37:15 PM
Amost 100m women. Just the US: Brea (4)
CYDY CytoDyn Inc
05/11/2025 6:11:30 PM
Drugs Approved to Prevent Breast Ca (4)
CYDY CytoDyn Inc
05/11/2025 12:35:01 AM
No longer thinking my "$50b" napkin (6)
CYDY CytoDyn Inc
05/10/2025 7:31:10 PM
Value of global oncology drugs mark (14)
CYDY CytoDyn Inc
05/09/2025 7:50:48 PM
If patients were eligible for debul (11)
CYDY CytoDyn Inc
05/09/2025 7:32:19 PM
Look @ this FDA accelerated approva (18)
CYDY CytoDyn Inc
05/09/2025 11:41:13 AM
FDA new Ai mandate --- https://stoc (5)
CYDY CytoDyn Inc
05/09/2025 6:02:03 AM
Then he should give BTD / Accelerat (5)
CYDY CytoDyn Inc
05/09/2025 12:46:26 AM
Dec. 17, 2024: -- As previously ann (6)
CYDY CytoDyn Inc
05/08/2025 8:15:20 AM
& we still have news coming on : am (5)
CYDY CytoDyn Inc
05/08/2025 4:08:59 AM
Lymphedema affects an estimated 140 (8)
CYDY CytoDyn Inc
05/08/2025 2:32:24 AM
We could very possibly be loaded fo (4)
CYDY CytoDyn Inc
05/08/2025 1:58:34 AM
Being BTD was already press release (2)
Go to page:
  • << First
  • < Previous
  • 3
  • 4
  • Next >

Recent Articles

  • Meet Jay Malave: Boeing's New CFO and His Inspirational Path
  • Area 52 Launches Nationwide Delivery by Online Dispensary
  • Sen. Sanders Raises Alarm on Corporate Ownership Power Shift
  • Pond Technologies Highlights Financial Success with New Statements
  • Investors Eye Key Stock Movements in Leading Tech Companies
  • Cultural Ties Strengthened: Chen Jinggu Festival Unites Regions
  • DRC Medicine and Ribbon Acquisition Join Forces for Growth
  • Rakovina Therapeutics Plans Amendments to Debentures and Warrants
  • Raoul Pal Applauds Robinhood's Tokenized Stocks Revolution
  • Dyne Therapeutics Sets $200 Million Common Stock Offering
  • Dyne Therapeutics Secures $200 Million in Stock Offering
  • Cathie Wood's Strategic Shifts: Focusing on AMD and Exiting Coinbase
  • Growing Movement for Child Care Solutions Gains Momentum
  • Growing Initiative Calls for Solutions to Child Care Needs
  • Exploring AI's Impact on Culture Through Art and Reflection
  • Sarepta Therapeutics Faces Class Action Amid Safety Concerns
  • Investigation into GoHealth and Others Sparks Investor Interest
  • Legal Actions Impacting Hims & Hers Health Shareholders
  • Acceleware's Innovative Strategy for Debt Reduction and Growth
  • Investigating The MathWorks, Inc. Data Breach Claims
  • Understanding Class Action Lawsuits and Their Impact on Investors
  • Insights into Apple and Sable Investigations and Impacts
  • Investors Need to Know About Recent Class Actions Against Major Companies
  • Investor Alert: Class Action Lawsuits Against Multiple Firms
  • Meta's Innovations in VR: The Future of Mobile Technology
  • Acceleware Initiates Non-Brokered Placement to Innovate Technology
  • Understanding the Class Action Against DoubleVerify Holdings, Inc.
  • Shell Takes Major Step Forward with Innovative LNG Project
  • Celebrating Healthier Choices through the ADD MILK! Campaign Success
  • UroGen Pharma's Future Hinges on URGN Class Action Details
  • Understanding the Securities Claims Against TechTarget Inc.
  • Red Cat Holdings: Key Updates and Investor Notices Unveiled
  • Silver Viper Minerals Boosts Private Placement to $3.6M
  • Explore the Latest Summer 2025 Diamond Certified Directory Update
  • NMP Acquisition Corp. Sets Stage for $100 Million IPO Success
  • Western Uranium & Vanadium Engages New Transfer Agent Following AGM
  • Mesoblast Approaches FDA Approval for Groundbreaking Therapy
  • Oliveda International, Inc. Expands Waterless Beauty to Canada
  • Organon & Co. Investors Alert: Class Action Filing Reminder
  • Krispy Kreme: Faced with Legal Actions and Market Fluctuations
  • Swiss Water Secures Warrant Purchase from Mill Road Capital
  • Exploring Breakthroughs in Space Tech: Rocket Lab and AST SpaceMobile
  • Achieve Life Sciences Secures $45 Million in Stock Offering
  • Class Action Update for Sarepta Therapeutics Investors
  • Purpose Investments Inc. Unveils New Distribution Schedule 2025
  • Amazing Growth of HCA Healthcare Revealed Over a Decade
  • PepGen Inc. Faces Class Action: Investor Counsel Alert
  • The Growth Journey of a $100 HubSpot Investment Over Five Years
  • Investors Should Stay Alert: Petco Class Action Insights
  • Celebrating Excellence: Robert Michael & Co.'s Real Estate Triumph
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site